Related references
Note: Only part of the references are listed.Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer.: Results from the GEPARTRIO study
G. von Minckwitz et al.
ANNALS OF ONCOLOGY (2008)
Quality-of-life in elderly patients with cancer:: A short review
Ulrich Wedding et al.
EUROPEAN JOURNAL OF CANCER (2007)
Clinical epidemiology of breast cancer in the elderly
W. J. Louwman et al.
EUROPEAN JOURNAL OF CANCER (2007)
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: A systematic review
Nicole M. Kuderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
M. S. Aapro et al.
EUROPEAN JOURNAL OF CANCER (2006)
2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
Adjuvant docetaxel for node-positive breast cancer
M Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer:: 10-year follow-up results of The French Adjuvant Study Group 05 randomized trial
J Bonneterre et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: A multicenter, double-blind, placebo-controlled phase III study
CL Vogel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma -: Pooled analysis of 2805 patients
E Bria et al.
CANCER (2005)
The colony-stimulating factors: use to prevent and treat neutropenia and its complications
RS Komrokji et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma
GH Lyman et al.
CANCER (2003)
Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients
RCF Leonard et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
